32P-postlabelling analysis of adducts formed by mitoxantrone and ametantrone with DNA and homopolydeoxyribonucleotides after enzymatic activation.
DNA adduct formation by enzymatically activated mitoxantrone and ametantrone has been studied by 32P-postlabelling method. Both drugs were activated by peroxidase/hydrogen peroxide system and formed several DNA adducts when reacted with calf thymus DNA. Mitoxantrone gave 3 and ametantrone 4 different DNA adducts with apparently similar chromatographic features suggesting that DNA adducts formed by both compounds do not differ significantly in their chemical structure. Despite this similarity, the level of DNA modification is 10 times higher for mitoxantrone compared to ametantrone. We did not observe DNA adducts in control samples where both drugs were incubated with DNA in the absence of the activating system. It indicates the importance of oxidative activation of mitoxantrone and ametantrone for their ability to bind covalently DNA. In order to identify nucleobases involved in the formation of DNA adducts by anthracenediones, polydeoxyadenosine, polydeoxythymidine, deoxyguanosine 3'-monophosphate and deoxycytosine 3'-monophosphate were modified by mitoxantrone and ametantrone activated in the above mentioned oxidating system. We proved that the only nucleobase modified by both drugs is guanine with no alkylation observed at other DNA bases. The pattern of adducts formed with deoxyguanosine 3'-monophosphate is reminiscent of that obtained with calf thymus DNA. In addition, mitoxantrone was found to be phosphorylated during the postlabelling procedure, most probably at the 1,4-hydroxyl groups of the chromophore. Ametantrone which does not possess hydroxyl groups attached to the chromophore core was resistant to phosphorylation by T4 polynucleotide kinase and gamma-[32P]ATP. These results for the first time provide direct evidence that mitoxantrone and ametantrone form DNA adducts when activated by oxidation in vitro.
Department of Pharmaceutical Technology and Biochemistry, Technical University of Gdansk, Poland.
P
P
Dackiewicz
A
A
Skladanowski
J
J
Konopa
D000818:Animals; D000970:Antineoplastic Agents / Q000378:metabolism*; D001345:Autoradiography; D001711:Biotransformation; D002417:Cattle; D002855:Chromatography, Thin Layer; D004247:DNA / Q000187:drug effects / Q000378:metabolism; D018736:DNA Adducts / Q000378:metabolism*; D006147:Guanine / Q000378:metabolism; D006735:Horseradish Peroxidase / Q000378:metabolism; D006861:Hydrogen Peroxide / Q000378:metabolism; D008942:Mitoxantrone / Q000031:analogs & derivatives* / Q000737:chemistry / Q000378:metabolism*; D010084:Oxidation-Reduction; D010761:Phosphorus Radioisotopes; D011089:Polydeoxyribonucleotides / Q000378:metabolism
D000970:Antineoplastic Agents; D018736:DNA Adducts; D010761:Phosphorus Radioisotopes; D011089:Polydeoxyribonucleotides; D006147:Guanine; D004247:DNA; D006861:Hydrogen Peroxide; D008942:Mitoxantrone; D006735:Horseradish Peroxidase; C020182:ametantrone